Unveiling the Neural Mechanisms of 5-HT7 in Sleep Apnea Induced by Arousal Dysregulation

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Obstructive sleep apnea (OSA), recognized as a highly prevalent sleep breathing disorder with severe complications, features a complex etiology. Poor understanding of disease pathogenesis limits the overall efficacy of interventions. Studies have found that upregulation of 5-HT7 expression in the lateral hypothalamus (LH) could reduce arousal threshold (ArTH) and induce an inhibitory effect to the respiratory central, which was associated with hypoxic stimulation. Therefore, the investigators speculate that the structural/functional abnormalities of the arousal-respiratory neural circuit, mediated by LH5-HT7, may play an important role in the pathogenesis of OSA. To verify the hypothesis, the investigators will compare the ArTH and the brain network presenting by multimodal MRI in normal individuals, snoring individuals, and OSA patients, to reveal the correlation between arousal dysregulation and the structure/function of LH regions; compare the changes of ArTH and brain network in OSA patients with low ArTH before and after CPAP treatment, to verify the interaction between hypoxia and arousal dysregulation, as well as whether the damaging performance of the arousal-respiratory brain regulation area in OSA patients can be partially reversed by relieving hypoxia. Above all, the joint application B team will further analyze the LH5-HT7 neural mechanism in the pathogenesis of OSA.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 60
Healthy Volunteers: t
View:

⁃ OSA Patients:

• Age between 20 and 60 years.

• Symptoms of sleep snoring and daytime sleepiness.

• Confirmed diagnosis of OSA following overnight sleep monitoring.

⁃ Simple Snorers:

• Age between 20 and 60 years.

• Symptoms of sleep snoring.

• Overnight sleep monitoring indicates not meeting the OSA diagnosis.

⁃ Healthy Controls:

• Age between 20 and 60 years.

• No symptoms of sleep snoring.

• Overnight sleep monitoring rules out the diagnosis of OSA.

Locations
Other Locations
China
No. 168 Litang Road, Changping District
RECRUITING
Beijing
Contact Information
Primary
Yingqian Zhou
yingqianzhou9112@126.com
010-56119472
Backup
Yue Yin
yinyue1217@126.com
86 17600807298
Time Frame
Start Date: 2024-08-30
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 140
Treatments
Non-OSA patients group
Healthy individuals (without snoring symptoms, AHI \< 5 events/h);Simple snorers (with snoring symptoms, AHI \< 5 events/h)
OSA patients
Patients diagnosed with OSA
Sponsors
Leads: Beijing Tsinghua Chang Gung Hospital

This content was sourced from clinicaltrials.gov